Evaluation of BTV100 in Subjects With Dry Eye Disease
Status:
RECRUITING
Trial end date:
2026-02-15
Target enrollment:
Participant gender:
Summary
This study will be a randomized, vehicle-controlled, double-masked, multiple-dose, parallel-group study to evaluate the efficacy, safety and tolerability of repeat dosing of Cevimeline Ophthalmic Solution compared to the vehicle in subjects with Dry Eye Disease (DED).